A thromboplastic factor has been demonstrated in human red cells by Shinowara (1951) , Ottaviani, Dettori, and Manai (1954) , Quick, Georgatsos, and Hussey (1954) , Leupold (1955) , Bounameaux (1957a) , and Georgatsos, Hussey, and Quick (1955) , and named the "erythrocyte clotting factor" (E.C.F.). Its activity is similar though not identical with that of platelet factor 3. Thromboplastic activity is not produced by whole erythrocytes, but only after lysis by freezing or dilution with distilled water. Lysed erythrocytes increase the prothrombin consumption of plateletpoor or platelet-rich plasma and restore to normal the prolonged recalcification time and the impaired prothrombin consumption of a thrombocytopenic plasma (Georgatsos et al., 1955) . The E.C.F. activity depends on the presence of thromboplastinogen (Izarn, Hussey, and Quick, 1955) . The increase of prothrombin consumption of a platelet-free haemophilic plasma, to which thromboplastinogen is added, is higher when platelets are replaced by lysed erythrocytes, when there is a linear relationship between this increase and the amount of thromboplastinogen.
The prothrombin consumption test in the presence of lysed erythrocytes, as suggested by Izarn et al. (1955) , should therefore be very sensitive in detecting small quantities of thromboplastinogen or antihaemophilic globulin (A.H.G.) and it should be useful in differentiating between mild and severe A.H.G. deficiencies.
It was also shown by Leupold (1955) , Georgatsos et al. (1955) , and Bounameaux (1957a) that lysed red cells can be substituted for platelets in the thromboplastin generation test of Biggs and Douglas (1953) .
This paper records an investigation into the coagulation properties of lysed erythrocytes. The possible interference of lysed erythrocytes in the various stages of the clotting process has been investigated and a study made as to whether other activities might be detected in red cells comparable with those already found in platelets by Deutsch, Johnson, and Seegers (1955) . A preliminary report on the antiheparin activity of lysed erythrocytes has been published (Serafini and Centurelli, 1957) . Methods Preparation of Lysed Erythrocytes (Haemolysate).
-Nine volumes of human blood, taken into siliconed glassware after a clean venepuncture from a healthy person, were mixed with one volume of 0.1 M sodium oxalate and then centrifuged at 800 r.p.m. for five minutes. The platelet-containing plasma was pipetted off and the packed red cells were washed eight times with buffered saline, which, after slow centrifugation, was removed. After the last washing, red cells were centrifuged at 5,000 r.p.m. for 30 min. and the supernatant saline was removed. A concentrated haemolysate, obtained by freezing at -20' C. for 12 hours, was obtained from a suspension of 8-10,000,000 red cells per c.mm., containing only 500-2,000 platelets or their fragments per c.mm. After thawing, the haemolysate was stored at -20' C. and warmed to 370 C. before the experiments. Different dilutions of haemolysate in buffered saline (imidazole buffer at pH 7.3) were used. (Table II) . to normal plasma, together with 0.025 M CaC12. group.bmj.com on July 6, 2017 -Published by http://jcp.bmj.com/ Downloaded from U. M. SERAFINI and G. CENTURELLI cases of haemophilia to which haemolysate was added before clotting was restored to normal, but it was only improved, though remaining abnormal, in blood from patients with severe haemophilia or Christmas disease (Table III) . These results agree with the observations of Georgatsos et al. (1955) and Izarn et al. (1955) that the thrombin generation of a haemophilic plasma is increased when haemolysate is substituted for platelets in the test of Pitney and Dacie (1953) (Table IV) . Antiheparin Activity.-Lysed erythrocytes show a marked antiheparin activity comparable to the activity of a concentrated platelet suspension, and it is directly proportional to the concentration of haemolysate and not inhibited by an excess. It is poor when 1 in 50 diluted samples are used (Fig. 2) . It is stable to temperature (600 for 30 min.) and storage and does not decrease after treatment with BaSO4. The antiheparin effect of haemolysate is rapid and does not increase after incubation with heparinized plasma.
Effect on Other Coagulation Tests-Haemolysate does not significantly influence the thrombin-fibrinogen reaction, but in the most concentrated samples there is a slight inhibitory action. On the contrary, platelets show a slight but constant accelerating effect (Table V) . Platelet suspension (300,000 per c.mm.) The clotting time of platelet-poor normal plasma to which Russell's viper venom and CaCl2 were added (" stypven " time) was markedly accelerated by the haemolysate. The accelerating activity depends on the concentration of the added haemolysate and is still present in a dilution of 1 in 1,000. The strongest activity is shown by haemolysate diluted 1 in 10. It does not change when using more concentrated samples (Table VI) .
The highest concentrations of haemolysate inhibit the Quick time of platelet-poor normal plasma. A similar inhibiting effect of the less dilute samples of haemolysate was observed in the test for factor VII, which was not shown in the test for factor V activity. Very slight factor V activity was observed in undiluted haemolysate and it is probably due to absorbed proteins that could not be washed off the erythrocytes (Table VI) .
The factor VII activity of a normal serum decreases slightly after incubation with excess haemolysate and persists unchanged if incubated with diluted samples (Table VI) . No evidence of any inhibitory effect of the haemolysate on brain thromboplastin or plasma thromboplastin was shown in our experiments. No clot-retraction promoting activity was observed in the haemolysate. Reagents: 0-1 ml. Brain Thromboplastin 0-1 ml. 0-1 ml. Normal Serum +0-1 ml. 0025 M CaCd2
Platelet-poor 0-1 ml. Seitz- 
Discusion
It is known that erythrocytes contain a thromboplastic factor, probably of a lipoid nature and with a platelet-like activity. It can be substituted for platelets in the thromboplastin generation test or in the prothrombin utilization test and in assessing thrombin formation. It has been used by Bounameaux (1957b) for the assay of A.H.G. The preparation of a washed platelet suspension takes time (Wolf, 1956 ) and its activity deteriorates on storage due to clumping of platelets. Haemolysate, on the contrary, is fairly stable and easy to prepare. The use of a haemolysate instead of platelets might therefore be useful in coagulation tests. Our results show that in clotting tests the use of haemolysate to replace platelet suspensions is inconvenient as it makes these tests less sensitive for the detection of A.H.G. deficiencies.
It seems that the highest concentrations of lysed erythrocytes have an inhibitory effect on clotting. Similar results were obtained using concentrated platelet suspensions or lipid extracts from platelets and from brain in thromboplastin generation tests (Larrieu, Caen, and Bernard, 1955; Bounameaux, 1957a) and in prothrombin consumption tests (Wolf, 1956) . Wolf believed that the inhibition exerted by excess lipid or platelets was due to a blockage of the reaction between thromboplastin and proconvertin (factor VII) because it does not occur in the " stypven " time. On the other hand, Bounameaux (1957a) found that excess platelets increase the rate of inactivation of plasma thromboplastin.
We did not find that haemolysate had any antithromboplastin action after incubation either with brain or plasma thromboplastin. Since inhibition is exerted by concentrated haemolysate on thromboplastin and thrombin generation and on Quick time, while it does not occur in the presence of Russell's viper venom, this action is probably identical with that previously described for excess lipid and platelets. Our results support such a view. It cannot, however, be explained by this theory why inhibition takes place during plasma thromboplastin generation, for which, according to Ackroyd (1956) , factor VII should not be required. Slight inhibition by the concentrated haemolysate of the thrombin-fibrinogen reaction was also observed.
We cannot explain whether inhibition from excess haemolysate might be due to a specific antithromboplastic substance, such as Tocantins' lecithin fraction from brain (Tocantins, Carroll, and McBride, 1948) , or to a different activity of the same thromboplastic factor at different concentrations. Wolf (1956) and Bounameaux (1957a) believe that gross excess of one clotting factor can cause an inhibitory effect. On the other hand, Barkhan, Newlands, and Wild (1956) have isolated two phospholipids, phosphatidylethanolamine and phosphatidyl-serine, from acetone-dried brain tissue, the former accelerating and the latter inhibiting plasma thromboplastin generation. Therefore, the possibility of the presence in the erythrocytes of various phospholipids with different accelerating or inhibiting activities cannot be excluded.
Erythrocytes as well as platelets can block the antithrombin activity of heparin. According to Deutsch et al. (1955) platelet antiheparin factor is different and separable from the thromboplastic factor by ultracentrifugation. The heparinneutralizing faculty of red cells behaves like the erythrocyte thromboplastic activity, but it is much less in progressive dilutions of the haemolysate and it is not inhibited by an excess. Because of the different mechanism of the two activities, there is no evidence to assume the existence of two different factors in erythrocytes.
The lipoid factor, isolated from erythrocytes by de Vries, Kettemborg, and van der Pol (1956) , was claimed to be devoid of antiheparin activity, but actually it was inactive on the thromboplastin generation test also and it could only shorten the "stypven " time. Therefore, the only evidence following from de Vries' results is that the accelerating effect on "stypven " time is not always associated with thromboplastic activity and cannot be identified with it. Summary The activity of lysed human erythrocytes in the various stages of the clotting process was investigated. Some characteristics of erythrocyte thromboplastic activity were defined by the use of different tests. The mechanism of the inhibitory effect of concentrated haemolysate was investigated. It may be due to an inhibition of factor VII. Slight antithrombin activity was also observed. It was found that the use of haemolysate as a substitute for platelets makes clotting tests less sensitive to detect A.H.G. deficiencies.
A stable antiheparin activity was detected in erythrocytes.
